The adaptability and innovative capacity of CROs highlighted in EUCROF survey.
Martine Dehlinger-Kremer, PhD
Advertisement
Articles by Martine Dehlinger-Kremer, PhD
Successful collaborations between Pharma/Biotech/Device industries and CROs will play a key role in an effective fight against the global COVID-19 pandemic.
Advertisement
Latest Updated Articles
The Current Status of European Research Related to COVID-19: The EUCROF PerspectivePublished: January 25th 2021 | Updated:
COVID-19 Pandemic Exemplifies the Benefits of CROsPublished: May 24th 2023 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Verzenio and Kisqali Deliver Positive Long-Term Results in Early Breast Cancer Trials
2
AstraZeneca’s Phase III POTOMAC Trial Shows Imfinzi Significantly Improves Disease-Free Survival in High-Risk NMIBC
3
Honing the Power of AI for Next Generation Trial Oversight and Execution
4
Accelerating Development Through Parallel Execution and Rigorous Quality Controls
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
